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Abstract
Background: Irritable bowel syndrome (IBS) is commonly regarded as a functional disorder, and is hypothesized to
be associated with anxiety and depression. This evidence mainly rests on population-based studies utilising self-
report screening instruments for psychopathology. Other studies applying structured clinical interviews are generally
based on small clinical samples, which are vulnerable to biases. The extant evidence base for an association between
IBS and psychopathology is hence not conclusive. The aim of this study was therefore to re-examine the hypothesis
using population-based data and psychiatric morbidity established with a structured clinical interview.
Methods: Data were derived from a population-based epidemiological study (n = 1077). Anxiety and mood
disorders were established using the Structured Clinical Interview for DSM-IV-TR (SCID-I/NP) and the General Health
Questionnaire (GHQ-12). Current and lifetime IBS was self-reported. Hypertension and diabetes were employed as
comparison groups as they are expected to be unrelated to mental health.
Results: Current IBS (n = 69, 6.4%) was associated with an increased likelihood of current mood and/or anxiety
disorders (OR = 2.62, 95%CI 1.49 - 4.60). Half the population reporting a lifetime IBS diagnosis also had a lifetime
mood or anxiety disorder. Exploratory analyses demonstrated an increased prevalence of IBS across most common
anxiety and mood disorders, the exception being bipolar disorder. The association with IBS and symptoms load
(GHQ-12) followed a curved dose response pattern. In contrast, hypertension and diabetes were consistently
unrelated to psychiatric morbidity.
Conclusions: IBS is significantly associated with anxiety and mood disorders. This study provides indicative
evidence for IBS as a disorder with a psychosomatic aspect.
Background
Gastrointestinal symptoms like heartburn, constipation,
diarrhoea and nausea are common in the general popu-
lation. In a large population-based health survey, 48% of
participants reported at least one symptom during the
last year [1]. Irritable Bowel Syndrome (IBS) is one of a
number of Functional Bowel Disorders (FBDs) defined
as “a functional bowel disorder in which abdominal pain
or discomfort is associated with defecation or a change
in bowel habit, and with features of disordered defeca-
tion” [2]. The prevalence of IBS is estimated to be in
the range of 2.9 to 11.4% with variations across contexts
and diagnostic criteria [3-5]. The overall prevalence of
IBS was 11.5% in a survey of 40,000 individuals in 8
European countries [6]. The syndrome is reported to
have a higher prevalence in women [3].
The organic aetiology of gastrointestinal symptoms is
often unclear, but these symptoms are associated with
symptoms of anxiety and depression [7] in a similar pat-
tern to that found for other somatic symptoms that also
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have an uncertain organic aetiology [7,8]. Both clinical
and population-based studies applying screening instru-
ments for anxiety and depression have found similar
increased rates of psychological distress in patients with
IBS [4,9]. It has, however, been suggested that psycho-
pathology among IBS patients is a function of other
patient characteristics than the disease [10]. Anxiety and
depression have been reported to independently increase
health care utilization in patients with IBS [9,11],
whereas a study utilising the General Health Question-
naire (GHQ-12) reported that IBS was associated with
more psychiatric distress, regardless of medical care-
seeking [12]. However, another well powered popula-
tion-based study of young adults from New Zealand
reported no association between IBS and symptoms of
mental disorder [13]. Currently, there is no evidence for
a common genetic component in the co-occurrence of
Major Depressive Disorder (MDD) and IBS [14].
Little is known about factors influencing the onset of
IBS. One study suggested poor quality of life as a risk
factor [15] and another reported a history of abuse to be
increased among subjects with IBS [16]. Others have
suggested IBS to be a functional disorder, characterized
by medically unexplained symptoms and often increased
impairment [17-19]. The aetiology of functional disor-
ders is still largely unknown, but it is believed that psy-
chological stress may be a causative factor [20], and
psychiatric comorbidities are common across functional
disorders [18].
Despite many studies on psychiatric morbidity in IBS,
there are still four issues to be addressed: First, the
majority of studies are based on clinical samples rather
than population samples. These studies are vulnerable
to bias, as psychological morbidity is shown to increase
help seeking in IBS [11], which may inflate observed
associations and lead to type 1 errors. Second, relatively
fewer studies have investigated the hypothesized associa-
tion between psychiatric morbidity and IBS in commu-
nity samples. Population-based studies need to be large
as the prevalence of IBS is moderate [3-5]. Conse-
quently, population-based epidemiological studies of the
IBS-mental health association generally have to rely on
self-reported symptoms of psychological distress rather
than psychiatric diagnoses derived from thorough and
expensive structured clinical interviews. To the best of
our knowledge, no population-based studies exist exam-
ining the IBS-mental health association utilising psychia-
tric diagnoses derived from clinical interviews. And
third, not all studies of the IBS-mental health associa-
tion have reported positive findings [13]. Among clinical
studies using the SCID interview, there are also negative
findings [21]. And fourth, not only are many of the
reported positive associations based on potentially
biased clinical samples, but also on relatively small
sample sizes. There is also potential publication bias in
favour of positive findings.
The aim of the present study was to re-examine the
hypothesized IBS-mental disorder association in the
context of a relatively large (n = 1077) population-based
health study, applying interview based clinical diagnoses
for psychiatric morbidity in addition to self-administered
screening instruments. To exclude the possibility of bias
producing observed associations between psychopathol-
ogy and IBS, we also examined the associations of
diabetes and hypertension to psychopathology. These
comparison disorders were chosen as they are not
regarded to be functional disorders, and we expected
weak or no associations of these disorders with psycho-
pathology [22-24].
Methods
Study design
The Geelong Osteoporosis Study (GOS) is a large epide-
miological study involving subjects selected from elec-
toral rolls for the Barwon Statistical Division, a region
defined by the Australian Bureau of Statistics. The area
is well suited to epidemiological research as it has a
defined population consisting of a range of social, cul-
tural and geographical settings, with a centralised health
provider. The total population and female population
according to the 2006 census was 259,013 and 132,124
(98,740 aged 20 years and over), respectively. An age-
stratified, random, population-based sample of 1,494
women (ages 20-94 yr) was recruited between 1994 and
1997 with a minimum of 100 in each 5-yr age stratum
between ages 20 and 69 and 200 in the age 70-79 yr
group and in the over 80 yr group. Of the 2,390 eligible
invitees, 1,494 women consented to participate, with a
response of 77.1% [25]. These women have continued to
return for biennial assessment with participation rates of
between 70-88%. A further cohort of 200 women aged
20-29 years was also recruited at the time of the 10-yr
follow up to allow for the full adult age range to con-
tinue to be investigated. Comparisons between the Bar-
won Statistical Division characteristics and the
Australian female population indicate that this is a
representative sample of Australian women [25].
From a potential pool of 1094 women who had parti-
cipated in the GOS 10-year follow-up, participants for
whom psychiatric or medical data were not available
(n = 17) were excluded from the analyses, resulting in a
final sample of 1077 women aged 20-93 years available
for analysis. All participants were female, and the age
distribution was almost uniform as a consequence of the
sampling procedure, with sample sizes across decades
ranging from 20-29 to 80-89 of n = 201, 147, 175, 179,
160, 134 and 81 respectively. The Barwon Health
Human Research Ethics Committee approved the study,
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and written informed consent was obtained from all
participants.
Assessment of psychiatric conditions by personal
interviews
Two specially trained interviewers (LW and FJ, co-authors
of this paper) performed all interviews personally. The
Structured Clinical Interview for DSM-IV-TR Research
Version, Non-patient edition (SCID-I/NP) was used. This
is a validated, semi-structured clinical interview for the
major axis I psychiatric disorders in the DSM-IV-TR.
Trained researchers, blinded to the participant’s medical
information, carried out the SCID-I/NP assessments.
Psychiatric disorders assessed included major depressive
disorder, minor depression, dysthymia, and bipolar disor-
der. Past and current anxiety disorders including panic
disorder, agoraphobia, social phobia, specific phobia,
obsessive-compulsive disorder, generalised anxiety disor-
der (current only), anxiety disorders due to a general med-
ical condition, substance induced anxiety disorder and
anxiety disorders not otherwise specified were also
assessed.
The General Health Questionnaire (GHQ-12) was
used as an additional continuous measure of depressive
symptoms [26]. This is a well-established screening
instrument designed to detect non-psychotic psychiatric
disorders in community and medical settings using a
12-item self-report questionnaire based on the respon-
dent’s assessment of their present state. Each item is
scored on a four-point Likert scale. To create a continu-
ous score with as wide a range as possible, these
answers were summed to give a final score for each par-
ticipant with a potential range of 12-48.
A GHQ-12 total scale cut-off at the 80th percentile
was defined for categorical analyses, and was used for
secondary analyses. The Kappa between the 80th percen-
tile GHQ-12 (defining 218 cases among 1060 with valid
responses to the GHQ-12) and current anxiety or mood
disorder as defined by the SCID interview was 0.35
(84 overlapping cases among 147 individuals with cur-
rent SCID-defined psychiatric morbidity).
Assessment of IBS
Current and lifetime IBS was assessed in a clinical inter-
view conducted prior to the SCID-I/NP interview. Parti-
cipants were asked whether or not they had ever had
IBS, which was included as one of many medical condi-
tions. In addition, participants were asked to state the
age of onset and whether or not the condition was pre-
sent in the last 12 months.
Assessment of diabetes and hypertension
Hypertension was defined as either systolic or diastolic
blood pressure above the 95th percentile, or current
medication for hypertension. Cut-offs for 95th percentile
blood pressure were based on age- and gender stratified
population data [27]. Appropriately qualified research
assistants measured blood pressure using a digital meter
(A&D Company, model UA-751) with the cuff placed
on the right upper arm and with the arm resting on a
table and the participant seated.
Current diabetes was self-reported on the same basis
as the IBS report. Self-report of diabetes is regarded to
be reliable [27]. Additionally, data regarding medication
use for both diabetes and hypertension was also self-
reported, and these data were used to corroborate the
self-reported medical conditions. Both hypertension and
diabetes were chosen as comparison groups on the basis
of well-established organic aetiology, and reports of
weak or non-existing associations with psychiatric con-
ditions [22-24].
Confounders
Age and education were identified and tested as potential
confounding variables. Information regarding the highest
educational level attained was derived from baseline
assessments, and comprised five categories: from com-
pleted primary school (1) through to university or other
tertiary qualification (5). The educational level was widely
distributed with n = 491 in level 1 and 2 and n = 300 in
level 5. IBS (current and lifetime) were not significantly
related to age and educational level (all p > .18). Diabetes
and hypertension were associated with both age and edu-
cational level in directions as expected (p < .001). The
associations of psychiatric conditions with educational
level and age were not significant (all p > .071), however,
lifetime psychiatric conditions, and any lifetime anxiety
disorder in particular, were negatively associated with age
(p < .001 and p = .017 respectively). Nutritional factors
are well covered in this sample, and we have previously
found unhealthy eating habits to be associated with men-
tal disorders [28]. However, nutrition was excluded as a
potential mechanism for the association of interest as it
was unrelated to IBS (all p > .505). On the basis of these
bivariate associations, age and educational level were
included as potential confounding factors in further ana-
lyses. Further adjustment for measured BMI and waist
circumference was examined, but omitted from analyses,
as they did not account for the associations of interest.
Analysis and statistics
First, we cross-tabulated current IBS, diabetes and
hypertension across current mood and anxiety disorders.
Observed numbers and percentages of psychiatric condi-
tions within IBS, diabetes and hypertension were esti-
mated. Using the Chi-Square test and Fisher Exact test
in cases with expected counts in any cell of five or less,
the significance of associations was tested. These
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analyses were then repeated for lifetime IBS versus life-
time mood or anxiety disorders.
Logistic regression analyses were employed to estimate
the associations between IBS, diabetes and hypertension
(dependent variables) and psychiatric morbidity. Models
were adjusted for age and educational level. As these
adjustments had only marginal influence on observed
associations, adjusted models only were reported in tables.
In order to compare the results with studies applying
self-report screening instruments for psychopathology,
all models were repeated applying the 80th percentile on
the GHQ-12 as the exposure variable. Additionally, the
percentage of those reporting IBS was examined in each
centile of GHQ-12 score. The dose response association
was examined with regression models with IBS as
dependent variable, and GHQ (centiles) as independent.
Two extra models were included: First, we excluded the
two last centiles of the GHQ distribution, examining if
the eventual response association was apparent also
within the sub-clinical distribution. Second, we exam-
ined eventual curve linearity in the IBS GHQ association
by including also a quadratic term (GHQ centile vari-
able squared).
Finally, exploratory analyses examining IBS across all
psychiatric diagnoses (both current and lifetime) were
performed. We had no a priori hypotheses regarding
which psychiatric conditions were expected to be asso-
ciated with IBS. Results were presented as cross tabula-
tions, and as odds ratios with 95% confidence intervals,
adjusted for age and educational level.
Results
Current IBS was reported in 6.4% (69 of 1077 study par-
ticipants; 95% CI 4.9 - 7.9). The prevalence of lifetime
IBS was 8.4% (95% CI 6.8 - 10.1). No associations
between IBS and age or educational level were found.
The prevalence of IBS was comparable to the prevalence
of diabetes (5.5%, 95% CI 4.1 - 6.8). Hypertension was
defined in 30.9% of participants (95% CI 28.2 - 33.7).
IBS was consistently associated with mood and anxiety
disorders. Among participants reporting current IBS,
27.5% (95% CI 17.0 - 38.1) also fulfilled the criteria for a
current anxiety or mood disorder (table 1). In compari-
son, the prevalence of a current anxiety or mood disorder
was 14.0% (95% CI 11.9 - 16.1) across all study partici-
pants. After adjustment for age and educational level, the
odds ratio for current anxiety or mood disorder among
IBS sufferers was 2.62 (95% CI 1.49 - 4.60) (Table 1).
The association between current IBS with current mood
disorder was comparable to that of the current anxiety
disorder. Lifetime IBS and lifetime mood or anxiety dis-
order followed the same pattern. Among 91 lifetime IBS
cases, 46 (50.5%, 95% CI 40.3 - 60.8) had a lifetime diag-
nosis of mood or anxiety disorder, equivalent to an
adjusted odds ratio of 2.12 (95% CI 1.37 - 3.29) (Table 2).
No associations between mood or anxiety disorders
and diabetes or hypertension were found, either in
unadjusted (table 1) or adjusted models (table 3).
Secondary analyses of the same associations, applying
the 80th percentile cut-off of the GHQ-12 as marker of
psychiatric morbidity, confirmed all findings (table 1, 2
and 3). Associations tended to be somewhat stronger
applying the GHQ-12 cut-off for 80th percentile than for
analyses based on SCID-I/NP-diagnosed psychiatric
conditions.
A dose-response association was observed between
symptoms of anxiety and depression (as defined by
GHQ-12 centiles) and prevalence of lifetime and current
IBS (figure 1). Pearson correlations between GHQ cen-
tiles and IBS was 0.14 and 0.17 for current and lifetime
IBS respectively (p < .001). The dose response association
was statistically significant also within the sub-clinical
range of the GHQ distribution (excluding the two last
centiles) with person correlations of 0.07 (p = .040) and
0.09 (p = .008) for current and lifetime respectively.
There was a significant curve linearity in the IBS GHQ
association (p-values for quadratic terms for GHQ 0.021
and 0.019 for current and lifetime, respectively).
Finally, we performed exploratory analyses of psychiatric
diagnoses across IBS. With few exceptions, all psychiatric
conditions were increased in IBS. Among 10 current psy-
chiatric conditions with 10 or more cases (prevalence of
Table 1 Current IBS, hypertension and diabetes versus current mood disorder, anxiety disorder, and GHQ 80th
percentile case-level
Current mood or anxiety disorder Current mood disorder Current anxiety disorder GHQ >= 80th percentile #
Total sample 151 [14.0%]
(11.9 - 16.1)
91 [8.4%]
(6.8 - 10.1)
83 [7.7%]
(6.1 - 9.3)
217 [20.6%]
(17.8 - 22.5)
Current IBS 69 19 [27.5%]**
(17.0 - 38.1)
11 [15.9%]*
(7.3 - 24.6)
13 [18.8%]**
(9.6 - 28.1)
31 [44.9%]**
(33.2 - 56.7)
Diabetes 59 8 [13.6%]
(4.8 - 22.3)
5 [8.5%]
(1.4 - 15.6)
5 [8.5%]
(1.4 - 15.6)
10 [17.1%]
(7.4 - 26.5)
Hypertension 333 48 [14.4%]
(10.6 - 18.2)
31 [9.3%]
(6.2 - 12.4)
25 [7.5%]
(4.7 - 10.3)
61 [19.0%]
(14.2 - 22.5)
Numbers are observed N among total N = 1077 and [% for rows] and (95% CI)
* p < .001, ** p < .05, # Missing data in 17 individuals. Other data complete.
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approximately 1% or more), positive associations were
observed for all except bipolar spectrum disorders. How-
ever, only two of these associations (minor depression and
generalized anxiety disorder) were statistically significant
(table 4). A similar pattern was found for lifetime psychia-
tric conditions: among 12 lifetime psychiatric conditions
with a prevalence of 1% or more, positive associations
with IBS were observed for 11 of these. However, only life-
time major depressive disorder (MDD), MDD with recur-
rent episodes, and minor depression were statistically
significant (table 5). Examining the largely overlapping
confidence intervals, there was no solid empirical basis
to conclude an association between IBS and any specific
psychiatric condition (table 4 and 5).
Discussion
Main findings
IBS was consistently associated with psychopathology in
this study. Among individuals with current IBS, 27.5%
also had a current psychiatric mood or anxiety disorder
(OR = 2.62), and among lifetime IBS, 50.5% also had a
lifetime psychiatric condition (OR = 2.12). Associations
of IBS to psychopathology were equally strong in mood
and anxiety disorders, and the prevalence of all psychia-
tric conditions except bipolar disorder tended to be
increased in IBS (though not all statistically significant).
Strengths and limitations
There are three main strengths of this study, which
makes it a novel contribution to the existing literature:
Psychiatric conditions were defined applying semi-
structured clinical interviews rather than self-report by
screening instruments only. This increased the
reliability and validity of psychopathology diagnoses,
and enabled us to examine IBS across psychiatric diag-
noses. The findings reflected in the categorical data
were supported by the GHQ-12 dimensional measures
of psychopathology. The study sample was population-
based, avoiding potential selection biases emerging
from increased help seeking on the basis of psycho-
pathology in IBS [11], which might inflate effect sizes,
and potentially produce type I errors. Finally, the study
was generously powered to examine the association of
IBS to general psychopathology.
The main limitation of this study is that the IBS diag-
nosis was based on self-report rather than the use of
one or more of the established diagnostic criteria (Rome
I, Rome II or Manning). IBS may represent heteroge-
neous conditions, and our crude measure of IBS
obstructed analyses of eventual variations in occurrence
of mental disorders across IBS conditions. We cannot
exclude there being several different causal paths for dif-
ferent IBS conditions. In the large European study (over-
all prevalence 11.5%, n = 41,984) only 4.8% had been
formally diagnosed but a further 4.2%, 2.9% and 6.5%
met the Rome I, Rome II or Manning criteria respec-
tively [6].
Other studies have also shown that different formal
definitions of IBS result in very different prevalence
rates for the disorder [3-5]. The prevalence of current
IBS in our study (6.4%, 95% CI 4.9 - 7.9%) is between
the prevalences applying the Rome II (2.9%) and III
(11.4%) criteria [3]. In an Australian population-based
study set in New South Wales (n = 762, 51.1% female,
response rate 62.2%) 8.9% met Rome II criteria for IBS
[29]. In a larger Australian cohort (n = 4500, response
Table 2 Lifetime IBS versus lifetime mood disorder, anxiety disorder, and GHQ 80th percentile case-level
Lifetime mood or anxiety disorder Lifetime mood disorder Lifetime anxiety disorder GHQ >= 80th percentile #
Total sample 366 (34.0%) 308 (28.6%) 143 (13.3%) 207 (20.6%)
Lifetime IBS (N = 91) 46 (50.5%)** 40 (44.0%)** 19 (20.9%)* 40 (44.0%)**
Adjusted odds ratio
(95% CI)
2.12
(1.37 - 3.29)
2.08
(1.34 - 3.24)
1.86
(1.08 - 3.21)
3.48
(2.23 - 6.42)
Numbers are observed N among total N = 1077 and (% for rows).
* p < .001, ** p < .05, # Missing data in 17 individuals. Other data complete.
Table 3 Current psychiatric disorders (independent variables) in relation to current IBS, diabetes, and hypertension
(dependent variables), adjusted for age and educational level
Current mood or anxiety disorder Current mood disorder Current anxiety disorder GHQ >= 80th percentile #
Current IBS 2.62
(1.49 - 4.60)
2.29
(1.15 - 4.56)
3.19
(1.65 - 6.17)
3.69
(2.23 - 6.12)
Diabetes 1.14
(0.52 - 2.53)
1.18
(0.45 - 3.11)
1.41
(0.53 - 3.77)
0.77
(0.38 - 1.58)
Hypertension 1.26
(0.84 - 1.89)
1.39
(0.85 - 2.27)
1.17
(0.69 - 2.00)
0.85
(0.59 - 1.22)
Odds ratios with 95% confidence interval.
# Missing data in 17 individuals. Other data complete.
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rate 72%), the prevalence for IBS according to Manning,
Rome I, and Rome II criteria was 13.6%, 4.4%, and 6.9%,
respectively [30]. The concordance with definitions
according to formal criteria for IBS cannot be estab-
lished based on our data. However, it is unlikely that
poor validity of our measure of IBS would alone pro-
duce the observed associations between IBS and
psychopathology.
Both IBS [3] and common mental disorder [31] are
more common in women than men. Inclusion of women
only in this study is thus relevant for the association of
interest. While the GOS female cohort is known to be lar-
gely representative of the Australian female population
[25], inclusion of women only obviously restricts the gen-
eralisability of our findings. Furthermore, it is known that
non-participation in health studies is associated with
increased prevalence of mental disorders [32], disability
[33], and mortality [34]. It is thus likely our sample is
biased in a healthy direction, which might deflate observed
associations. Finally, by virtue of the cross-sectional design,
causality cannot be inferred.
The relatively low concordance between 80th percen-
tile case-level on the GHQ-12 and current anxiety or
Figure 1 Dose response association between current symptom
load of anxiety and depression (GHQ-12), and percent reporting
IBS (tests for trend p < .001). Dose response association for whole
range (p < .001), and also excluding the two last centiles of the GHQ
distribution (p = .040 and p = .008 for current and lifetime respectively).
The apparent curve-linearity in the GHQ IBS association was statistically
significant (p = .021 and p = .019 for current and lifetime respectively).
Table 4 Specific current psychiatric diagnoses in relation to current and lifetime IBS
Current IBS Lifetime IBS
Total
prevalence
% of
total
With
IBS
% with
IBS
Fisher exact
test
OR 95%
CI
With
IBS
% with
IBS
Fisher exact
test
OR 95%
CI
MDD + 49 4.5% 5 7.2% .229 1.9 0.7 -
4.9
5 5.5% .591 1.3 0.5 -
3.5
MDD Dysthmia + 63 5.8% 6 8.7% .280 1.7 0.7 -
4.1
6 6.6% .639 1.2 0.5 -
2.9
Dysthymia + 19 1.7% 2 2.9% .339 1.7 0.4 -
7.7
2 2.2% .669 1.3 0.3 -
5.6
Bipolar Spectrum - 24 2.2% 1 1.4% 1.000 0.6 0.1 -
4.8
2 2.2% 1.000 0.9 0.2 -
4.1
Minor Depression* + 13 1.2% 4 5.8% .007 6.8 2.0 -
23.0
4 4.4% .018 5.1 1.5 -
17.0
Generalised Anxiety
Disorder*
+ 10 0.9% 4 5.8% .002 10.9 2.9 -
40.2
4 4.4% .007 7.5 2.1 -
27.5
Panic Disorder + 14 1.3% 2 2.9% .219 2.5 0.6 -
11.8
2 2.2% .331 1.8 0.4 -
8.5
Agoraphobia with no
panic disorder
- 6 0.5% 0 0.0% 0 0.0%
Social Phobia + 10 0.9% 2 2.9% .127 3.8 0.8 -
18.3
2 2.2% .202 2.7 0.6 -
12.9
Specific Phobia + 32 2.9% 4 5.8% .137 2.2 0.7 -
6.6
5 5.5% .181 2.1 0.8 -
5.8
Obsessive Compulsive
Disorder*
+ 6 0.5% 2 2.9% .050 10.1 1.6 -
61.9
2 2.2% .084 7.2 1.2 -
43.8
Anxiety, not otherwise
specified
+ 12 1.1% 1 1.4% .544 1.3 0.2 -
10.7
1 1.1% 1.000 1.0 0.1 -
7.8
Psychiatric conditions with a prevalence of n < 6 were excluded for power reasons.
* p < .05 for current or lifetime IBS
+ association (significant or not) in positive direction
- association (significant or not) in negative direction
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mood disorder (kappa 0.35) indicates that the findings
of studies applying screening instruments only partly
describe the same cases as do studies applying thor-
ough clinical interviews to establish psychiatric mor-
bidity. Screening instruments like the GHQ-12 are
generally regarded as rough and approximate indica-
tors of psychopathology compared to the “gold stan-
dards” of clinical diagnoses. Given this, it is perhaps
somewhat surprising that the associations of IBS to
GHQ-12 defined case-level for the arbitrary 80th per-
centile appeared to be stronger than to that of clinical
diagnosis. However, this is consistent with previous
findings where screening instruments have impressive
predictive validity many years ahead for adverse out-
comes like mortality and disability [35-37]. Further,
examining confidence intervals, we cannot exclude the
possibility of this being a chance finding, and the dif-
ferences are by no means consistently statistically sig-
nificant. One explanation for the difference might be
that the broad group as defined by any current mood
or anxiety disorder is very heterogeneous, including,
for example, both the severe conditions of bipolar dis-
order and relatively more benign conditions such as
specific phobias.
Interpretation
Our finding of an IBS-mental health association is in
line with previous reports of positive associations [4,9],
but contrasts with some population-based studies [13]
and studies applying clinical interviews for psycho-
pathology [21]. Our finding of increased psychopathol-
ogy in IBS is not new. The novelty of our study is
mainly related to improved methodology: psychopathol-
ogy defined by clinical interview; a population based
design; and generous statistical power.
The most striking exception from the associations
between IBS and various mental disorders was bipolar
disorder. This might well be a type 2 error due to sam-
ple size. If replications confirm this lack of association,
it should be investigated whether this lack of association
is specific to IBS, or if is a pattern (or lack of such)
across other conditions.
The lack of associations of psychopathology to dia-
betes and hypertension was as expected, and in accor-
dance with findings from previous large population-
based studies [22-24]. These negative findings might be
of value for future meta-analyses. For the purpose of
this study, the lack of association of diabetes and hyper-
tension with psychopathology indicates that the
Table 5 Specific lifetime psychiatric diagnoses in relation to current and lifetime IBS
Current IBS Lifetime IBS
Total
prevalence
% of
total
With
IBS
% with
IBS
Fisher exact
test
OR 95%
CI
With
IBS
% with
IBS
Fisher exact
test
OR 95%
CI
MDD* + 247 22.6% 24 34.8% .017 2.0 1.2 -
3.4
30 33.0% .018 1.8 1.1 -
2.9
MDD Single Episode + 121 11.1% 8 11.6% .843 1.1 0.5 -
2.3
13 14.3% .290 1.4 0.7 -
2.6
MDD Recurrent Episodes* + 126 11.5% 16 23.2% .005 2.7 1.5 -
4.9
17 18.7% .039 2.0 1.1 -
3.4
MDD Dysthmia + 63 5.8% 6 8.7% .280 1.7 0.7 -
4.1
6 6.6% .639 1.2 0.5 -
2.9
Bipolar Spectrum - 24 2.2% 1 1.4% 1.000 0.6 0.1 -
4.8
2 2.2% 1.000 0.9 0.2 -
4.1
Minor Depression* + 31 2.8% 4 5.8% .126 2.2 0.7 -
6.4
6 6.6% .039 2.6 1.0 -
6.6
Panic Disorder + 59 5.4% 5 7.2% .413 1.4 0.5 -
3.6
7 7.7% .330 1.5 0.7 -
3.4
Agoraphobia with no
panic disorder
- 8 0.7% 0 0.0% 0 0.0%
Social Phobia + 23 2.1% 2 2.9% .652 1.3 0.3 -
5.9
2 2.2% 1.000 1.0 0.2 -
4.4
Specific Phobia + 36 3.3% 4 5.8% .279 1.9 0.6 -
5.6
5 5.5% .218 1.8 0.7 -
4.8
Obsessive Compulsive
Disorder
+ 14 1.3% 2 2.9% 1.000 2.7 0.6 -
12.7
2 2.2% 1.000 1.9 0.4 -
8.9
Anxiety NOS + 17 1.6% 2 2.9% .292 2.0 0.4 -
9.0
2 2.2% .647 1.4 0.3 -
6.4
Psychiatric conditions with a prevalence of n < 6 were excluded for power reasons.
* p < .05 for current or lifetime IBS
+ association (significant or not) in positive direction
- association (significant or not) in negative direction
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observed associations for IBS are not only a product of
response bias or selection bias.
How strong is the association of IBS and psycho-
pathology? Despite consistent associations, the majority
(72.5%) of individuals with current IBS had no current
psychopathology as defined by the structured clinical
interview. Applying the slightly more inclusive 80th per-
centile on the GHQ-12 identified 55.1% without case-
level GHQ-12 score among individuals with current IBS.
Among lifetime IBS, 49.5% had no lifetime psychiatric
diagnosis. Despite thorough clinical interviews for psy-
chiatric morbidity, we cannot exclude false negative
cases. Further, the contribution of sub-clinical case-
levels cannot be excluded. However, there is no evi-
dence, neither in this nor previous studies, for a history
of psychopathology in all individuals with IBS. The
opposite might also in some cases be true, that abdom-
inal pain or IBS preceded the psychiatric condition.
Our finding of an association between lifetime psy-
chiatric morbidity and current IBS is in accordance with
studies demonstrating that somatisation is associated
with incident IBS [38]. Others have found somatisation
to play a key role in explaining IBS, but not dyspepsia
[39]. Unfortunately, our study included no information
on somatisation, but the correlation between symptoms
of somatisation and symptoms of anxiety and depression
is reported to be strong in the general population [40].
IBS is suggested to be a functional disorder [17-19].
The term functional somatic syndrome is applied to sev-
eral related syndromes characterized more by symptoms,
suffering, and disability than by consistently demon-
strable organic or tissue abnormality. Other functional
disorders include multiple chemical sensitivity; the sick
building syndrome; repetitive stress injury; the side
effects of silicone breast implants; the Gulf War syn-
drome; chronic whiplash; the chronic fatigue syndrome;
and fibromyalgia [18]. Somatic symptoms are often
referred to as medically unexplained or functional when
the physician can find no objective organic explanation
to the patient’s symptoms or sufferings [17]. The aetiol-
ogy of functional disorders is still largely unknown. The
existence of many distinct functional somatic syndromes
has been questioned, with reference to overlap in case
definitions, reported symptoms, and non-symptom asso-
ciations [17,19,41]. It has been suggested that specific
functional disorders are mainly an artefact of medical
specialisation [17]. The prevalence of specific functional
disorders varies with geography and over time [17,18].
However, increased prevalence of psychiatric disorders,
particularly anxiety and mood disorders, seem to be a
common feature across functional somatic syndromes.
Psychosocial stress and psychopathology are increased
in all functional disorders, but not in all individuals with
the functional disorders, and is generally thought of as
being the cause rather than the consequence of func-
tional disorders [18]. The consistent association of IBS
with psychopathology is indicative, but not conclusive,
evidence of IBS as a functional disorder.
Conclusion
IBS is significantly associated with anxiety and mood
disorders. This study provides indicative evidence for
IBS as a disorder with a psychosomatic aspect.
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